期刊文献+

HPLC法测定盐酸洛美沙星分散片含量及有关物质 被引量:3

Determination of Lomefloxacin and its Related Substances in Lomeftoxacin Hydrochloride Dispersible Tablets by HPLC
下载PDF
导出
摘要 目的:采用高效液相色谱法测定盐酸洛美沙星分散片中洛美沙星的含量及其有关物质。方法:用AichromBond AQ C18(250 mm×4.6 mm,5μm)色谱柱,流动相:戊烷磺酸钠溶液(取戊烷磺酸钠1.5 g,磷酸二氢铵3.5 g,加水1 000 ml,使溶解,用磷酸调节pH至3.0)-甲醇(63∶37);有关物质检测采用梯度洗脱,检测波长:287 nm;柱温:40℃;流速:1.0 ml.min-1。结果:盐酸洛美沙星线性范围为0.022 3~0.223 4 mg.ml-1(r=0.999 9),平均回收率为99.5%(n=9)。样品中的杂质均能很好检出,各杂质与主峰之间的分离度良好,定量限为0.81 ng,检测限为0.32 ng。结论:含量测定方法重复性好,准确度高,有关物质检测方法专属性强,适于盐酸洛美沙星分散片的质量控制。 Objective: To establish an HPLC method for the determination of lomefloxacin hydrochloride and its related substances in lomefloxacin hydrochloride dispersible tablets.Method: An AichromBond AQC18 column(250 mm×4.6 mm,5 μm)was used,the mobile phase was sodium pentanesulfonate solution(dissolving 1.5g sodium pentanesulfonate and 3.5g ammonium dihydrogen phosphate in 1 000ml water,then adjusting pH to 3.0 with phosphoric acid)-methanol(63∶ 37),and the related substances were determined with gradient elution at detection wavelength of 287nm.Result: The linear range of lomefloxacin hydroxide was 0.022 3~0.223 4 mg·ml-1(r=0.999 9),and the mean recovery was 99.5%(n=9).Lomefloxacin and its related substances could be well separated.The limit of quantitation was 0.81ng and the limit of detection was 0.32ng.Conclusion: The method is sensitive,accurate and rapid.It is suitable for the quality control of lomefloxacin hydrochloride dispersible tablets.
出处 《中国药师》 CAS 2012年第9期1262-1264,共3页 China Pharmacist
关键词 高效液相色谱法 盐酸洛美沙星分散片 含量测定 有关物质 HPLC:Lomefloxacin hydrochloride dispersible tablets Determination Related substances
  • 相关文献

参考文献3

二级参考文献5

共引文献347

同被引文献44

  • 1刘艳华,杨大伟,郭桂芳,梁先明,段文龙.兽药有关物质研究中的常见问题[J].中国兽药杂志,2012,46(8):49-52. 被引量:1
  • 2钱东生,朱卫忠,姚姝姮,朱毅芳.国产盐酸洛美沙星体内外抗菌作用实验研究[J].中国药理学通报,1996,12(1):80-84. 被引量:7
  • 3国家药典委员会编.中国药典[s].二部.北京:化学工业出版社.2010.附录14.472.
  • 4宋丽,廖洪利,谢静,臧志和.色谱法检测药物杂质的研究进展[J].西南军医,2007,9(5):79-80. 被引量:6
  • 5ICH. Impurities in new drug substances[ EB/OL]. http://www, ich. org/fileadmin/Public Web _ Site/lCH_ Products/Guidelines/Quality/Q3A_R2/Step4/Q3A_R2 Guideline. pdf , 2006-10-25/2014-09-06.
  • 6EP[S]. 8. Oth ed. 2013. 765-767, 3268-3269, 169-171, 1462- 1464, 1470-1471, 1459-1460, 1502-1503, 1482-1484, 1595- 1596, 1533-1535.
  • 7USP[S].37thed.2014.2504,2472,4048-4049.
  • 8Rao RN, Prasad KG, Naidu CG, et al. Development of a validated liquid chromatographic method for determination of related substances of telmisartan in bulk drugs and formulations[ Jl. Journal of Pharma- ceutical and Biomedical Analysis, 2011, 56 ( 3 ) : 471-478.
  • 9Durga Rao D, Kalyanaraman L, Sait SS, et al. A validated stability- indicating normal phase LC method for clopidogrel bisulfate and its impurities in bulk drug and pharmaceutical dosage form[J]. Journal of Pha~eutical and Biomedical Analysis, 2010, 52( 1) : 160-165.
  • 10Bertolini T, Vicentini L, Boschetti S, et al. A novel automated hy- drophilic interaction liquid chromatography method using diode-array detector/electrospray ionization tandem mass spectrometry for analysis of sodium risedronate and related degradation products in pharmaceu- ticals[ J]. Journal of Chromatography A. 2014, 1365 : 131-139.

引证文献3

二级引证文献18

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部